When High Calcium Points to a Parathyroid Problem and How the Diagnosis Is Confirmed

A high calcium level on a routine blood panel is common, and one pattern points toward the parathyroid glands: elevated calcium paired with a parathyroid hormone (PTH) value that is high, or sitting inside the normal range when it should be low. That pairing defines primary hyperparathyroidism. The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism, published in the Journal of Bone and Mineral Research in 2022, states the requirement plainly: an elevated albumin-adjusted serum calcium in the presence of an elevated or inappropriately normal PTH. Reading the two numbers together, rather than either one alone, is what makes the diagnosis.

This article is educational and not medical advice.

Why calcium and PTH have to be read as a pair

Parathyroid hormone and calcium are locked in a feedback loop. When blood calcium falls, the four parathyroid glands release more PTH, which pulls calcium from bone, conserves it in the kidney, and helps activate vitamin D so the gut absorbs more. When calcium rises, healthy glands sense it and shut PTH down. That is the key to interpretation. In almost every cause of high calcium that does not involve the parathyroids, such as certain cancers, PTH is appropriately suppressed toward the bottom of the range.

Primary hyperparathyroidism breaks the loop. One or more glands secrete PTH autonomously, so the hormone stays high, or fails to fall, even as calcium climbs. The Workshop describes this as PTH being "inappropriately high for the serum calcium concentration," and it notes that the PTH figure can still land within the laboratory reference range. A normal-looking PTH is therefore not reassuring on its own. Paired with a high calcium, a mid-range PTH is the finding, because a healthy gland would have driven it far lower.

The three biochemical phenotypes

The Workshop organizes the diagnosis around three patterns.

Hypercalcemic disease with high PTH

This is the classic form: elevated albumin-adjusted calcium together with an elevated PTH, confirmed on at least two occasions. Most cases today are found incidentally and cause few symptoms, a shift from the older textbook picture of "bones, stones, abdominal groans." The biochemistry is unambiguous, and the main task becomes deciding who benefits from surgery versus monitoring.

Hypercalcemic disease with normal PTH

Here calcium is high but PTH sits within the reference range. Because a normal gland would suppress in this setting, an unsuppressed PTH still fits parathyroid autonomy. This is where the phrase "inappropriately normal" earns its weight, and it is a pattern that is easy to dismiss if the lab flags only values outside the range.

Normocalcemic disease

The newer and more debated phenotype is normocalcemic primary hyperparathyroidism: a persistently elevated PTH with calcium that stays normal. The Workshop defines it as persistently normal albumin-adjusted total and ionized serum calcium alongside elevated PTH on repeated measurements over a three- to six-month window.

Normocalcemic disease is a diagnosis of exclusion

The central caution around the normocalcemic form is that it can only be called primary once every reason for a secondary rise in PTH has been ruled out. A 2022 review in Archives of Endocrinology and Metabolism frames it the same way, describing normocalcemic primary hyperparathyroidism as a diagnosis reached only after excluding secondary forms of hyperparathyroidism.

Many ordinary conditions push PTH up while calcium stays normal, and each mimics the pattern. Vitamin D deficiency is the most frequent, which is why guidelines ask for a documented, adequate vitamin D level before labeling the disease primary. Reduced kidney function raises PTH, so the estimated glomerular filtration rate matters. Several medications, including lithium, thiazide diuretics, and drugs that limit calcium absorption, can do the same, as can conditions that impair calcium uptake in the gut and losses of calcium through the urine. Measuring ionized calcium, not only total calcium, is part of the workup, because a share of people thought to have normocalcemic disease turn out to have subtly high ionized calcium and therefore ordinary hypercalcemic disease.

Ruling out a common look-alike

One inherited condition deserves specific mention because getting it wrong can lead to an unnecessary operation. Familial hypocalciuric hypercalcemia produces high calcium with a normal or mildly elevated PTH, so it can read almost identically to primary hyperparathyroidism on a basic panel. The distinguishing clue is how much calcium leaves the body in the urine. In familial hypocalciuric hypercalcemia the kidney holds onto calcium, so urinary calcium is characteristically low, and the calcium-to-creatinine clearance ratio from a 24-hour collection helps separate the two. The values can overlap, and confirming the inherited form sometimes requires genetic testing. The practical point is that a careful evaluation confirms the parathyroid pattern and, just as importantly, excludes the conditions that imitate it.

How the current consensus was built

What gives the 2022 framework its weight is the process behind it. More than 50 experts worked across several task forces, applied GRADE methodology to the questions best suited to formal evidence review, and produced guidance that more than 65 organizations across upward of 35 countries have endorsed. For readers, the useful takeaway is a discipline rather than a single threshold to memorize: interpret calcium and PTH together, repeat abnormal results before acting, and treat a diagnosis, especially the normocalcemic form, as provisional until the common secondary causes have been checked and cleared.